Genomic Valley Biotech Share Price
55.67+2.65 (+5.00%)
+87.76% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Genomic Valley Biotech Share Price
55.67+2.65 (+5.00%)
+87.76% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Genomic Valley Biotech Share Price
55.67+2.65 (+5.00%)
+87.76% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Genomic Valley Biotech Share Price
55.67+2.65 (+5.00%)
+87.76% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Genomic Valley Biotech Share Price
55.67+2.65 (+5.00%)
+87.76% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Genomic Valley Biotech Share Price
55.67+2.65 (+5.00%)
+87.76% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Genomic Valley Biotech Share Price
55.67+2.65 (+5.00%)
+87.76% past 1 Year
News
Concord Enviro Cuts FY27 Revenue Growth and EBITDA Margin Guidance
Equity
CEWATER
India Services PMI Signals Continued Expansion In October
Broader Market
India October Composite PMI Signals Continued Private Sector Expansion
Broader Market
Gaja Reports Strong Year On Year Growth In Second Quarter Consolidated Net Profit
Equity
GAJA
Bharat Forge North America Truck Orders Decline Sharply In October
Equity
BHARATFORG
Sun Pharma Clarifies Eye Care Production Halt Linked To Quality Issues
Equity
SUNPHARMA
Metropolis Guides For FY27 EBITDA Margin Expansion On Pricing And Platform Completion
Equity
METROPOLIS
Solar Industries Expects To Surpass FY27 Revenue And EBITDA Guidance
Equity
SOLARINDS
Solar Industries Pinaka Orders May Generate Rs 2,600 Crore Inflows
Equity
SOLARINDS
Garuda Construction Q2 Revenue Rises Sharply Year On Year
Equity
GARUDA
Garuda Construction Reports Higher Second Quarter EBITDA And Margin
Equity
GARUDA
Garuda Construction Reports Strong Second Quarter Net Profit Growth
Equity
GARUDA
Metropolis raises laboratory usage outlook through fiscal year 2029
Equity
METROPOLIS
Highway Infrastructure Secures Rs 198.31 Crore CPWD Construction Contract
Equity
HILINFRA
Democrats Projected To Sweep Key US Midterm Election Races
Broader Market
US Midterm Election Results Show Democrats Leading In House Races
Broader Market
Gujarat Fluorochemicals Reports Strong Fluoropolymer Growth, Expands Refrigerant Capacity
Equity
FLUOROCHEM
SBI Targets 14 To 15 Percent Credit Growth With Strong Corporate Pipeline
Equity
SBIN
BEL Reaffirms FY27 Growth Targets Despite Strong First Half Performance
Equity
BEL
GE Vernova T&D India Secures Power Grid Award For 6,000 MW HVDC Project
Equity
GVT&D